Results 261 to 270 of about 148,376 (307)
Concurrent light chain and transthyretin cardiac amyloidosis: A case report and review of the literature. [PDF]
Medicine (Baltimore)Sun H +5 more
europepmc +1 more source
More Than Just a Plaque: A Diagnostic Challenge in a Case of Suspected Cutaneous Localized Nodular Amyloidosis. [PDF]
Clin Case RepShah S, Shrestha J.
europepmc +1 more source
Changing Patterns of Diagnosis and Survival in Transthyretin Cardiac Amyloidosis: A Multicenter Cohort Study. [PDF]
J Am Heart AssocSperry BW +14 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annual Review of Biochemistry, 1992
The biochemistry of amyloidosis as it relates to clinical medicine and experimental pathology is presented. Amyloidoses are complex disorders in which normally soluble precursors undergo pathological conformational changes and polymerize as insoluble fibrils with the beta-pleated sheet conformation.
Jean D. Sipe, A. S. Cohen
openaire +5 more sources
The biochemistry of amyloidosis as it relates to clinical medicine and experimental pathology is presented. Amyloidoses are complex disorders in which normally soluble precursors undergo pathological conformational changes and polymerize as insoluble fibrils with the beta-pleated sheet conformation.
Jean D. Sipe, A. S. Cohen
openaire +5 more sources
Hematology/Oncology Clinics of North America, 1999
Amyloidosis is considered rare but has an incidence similar to that of Hodgkin's disease and chronic granulocytic leukemia. The diagnosis should be considered in any patient with unexplained nephrotic-range proteinuria, heart failure, peripheral neuropathy, or hepatomegaly.
Dispenzieri, A, Lacy, MQ, Gertz, MA
openaire +3 more sources
Amyloidosis is considered rare but has an incidence similar to that of Hodgkin's disease and chronic granulocytic leukemia. The diagnosis should be considered in any patient with unexplained nephrotic-range proteinuria, heart failure, peripheral neuropathy, or hepatomegaly.
Dispenzieri, A, Lacy, MQ, Gertz, MA
openaire +3 more sources
Best Practice & Research Clinical Haematology, 2005
Amyloidosis is an uncommon plasma-cell dyscrasia with an incidence of eight patients per million per year. It is often difficult to recognize because of the myriad symptoms and vague nature of the clinical presentation. Symptoms include fatigue, dyspnea, edema, paresthesias, and weight loss.
Morie A, Gertz +3 more
openaire +2 more sources
Amyloidosis is an uncommon plasma-cell dyscrasia with an incidence of eight patients per million per year. It is often difficult to recognize because of the myriad symptoms and vague nature of the clinical presentation. Symptoms include fatigue, dyspnea, edema, paresthesias, and weight loss.
Morie A, Gertz +3 more
openaire +2 more sources
Current Opinion in Rheumatology, 1991
Amyloidosis is a disease involving the fibrillar deposition of proteins in a manner that uniformly leads to the presence of green birefringence on polarization microscopy after staining the involved tissues with Congo red. In the year summarized, a wide range of new information has accumulated about this disease.
A S, Cohen, L A, Jones
openaire +2 more sources
Amyloidosis is a disease involving the fibrillar deposition of proteins in a manner that uniformly leads to the presence of green birefringence on polarization microscopy after staining the involved tissues with Congo red. In the year summarized, a wide range of new information has accumulated about this disease.
A S, Cohen, L A, Jones
openaire +2 more sources